National Drug Strategy
National Drug Strategy

National Amphetamine-Type Stimulant Strategy Background Paper: Monograph Series No. 69

6.2 Domestic methamphetamine production

prev pageTOC |next page

Table of contents

It is estimated that 90% of ATS in the Australian illicit drug market is produced in Australia in clandestine laboratories, while the other 10% is imported (Schloenhardt, 2007). Predominantly, domestic production is focused on ATS of lower purity forms, such as base, and reports suggest that high purity crystal methamphetamine production takes place in Asia or elsewhere, and is subsequently imported into Australia (Schloenhardt, 2007). A significant proportion of ATS production occurs in small clandestine laboratories (clan-labs) located in private homes, car-boots and hotel rooms, which make detection in manufacturing and trade difficult for law enforcement agencies, particularly in rural areas (Schloenhardt, 2007). Domestic seizures reflect that production is smaller in scale, unlike, for example, in the United States, where supply is met by larger ‘super-labs’ (Schloenhardt, 2007).

Modes of production detected in Australia include:

According to the 2005-06 Illicit Drug Data Report (IDDR), the number of ATS laboratories detected in Australia has steadily increased from 10 in 1990 to 390 in 2005-06 (Australian Crime Commission, 2007) (see Table 6.1). However, since 2004 the number of dismantled laboratories appears to be stabilising. As the majority of clandestine laboratories had been producing meth/amphetamine using the hypo-phosphorous acid method (which requires pseudoephedrine as a precursor), this stabilisation may be partly due to the restrictions placed on the purchase of pseudoephedrine-based pharmaceutical products in early 2006 through Project STOP and other initiatives, such as restrictions on scheduling.

Methamphetamine production in Australia takes place in practically all states with further evidence of the impact of Project STOP evident from detections in Queensland. Queensland had the highest clandestine laboratory figures since 1997–98, however a significant decrease in the number of laboratories detected in 2005–06 was reported in this state, which may be attributed to the introduction of Project STOP in early 2006 (Australian Crime Commission, 2006). The IDDR reported a 42% decrease in clandestine laboratory detections in the Northern Territory in 2005–06, while there were significant increases in the number of detections in WA and Victoria (Australian Crime Commission, 2007). The submission from NDARC noted that there have been reports by consumers of domestic production of crystal methamphetamine. While evidence of domestic production of crystal methamphetamine is not documented in Australian Crime Commission (ACC) reports, there is considerable police concern at both federal level and state level that several sophisticated laboratories already discovered, were capable of making crystal methamphetamine. Therefore, concurrent sustained efforts to control domestic diversion of precursor chemicals and manufacture is needed to disrupt high levels of domestic production that occur within Australia.

Top of Page

Table 6.1: Number of clandestine laboratory detections by state and territory, 96/97-05/06
Table 6.1: Number of clandestine laboratory detections by state and territory, 96/97-05/06

a. Jurisdictional breakdown unavailable for 1996-97.
Source: ACC, Illicit Drug Data Report 2005-06, Canberra: ACC

Top of Page

prev pageTOC |next page